Kidney-specific expression of GFP by in-utero delivery of pseudotyped adeno-associated virus 9

Molecular Therapy Methods and Clinical Development

Volumn 1, Issue , 2014, Pages 14014-

  Picconi, Jason L ^a,b   Muff Luett, Melissa A ^b   Wu, Di ^b   Bunchman, Erik ^b   Schaefer, Franz ^c   Brophy, Patrick D ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^c Center for Pediatrics and Adolescent Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NEPHRIN;

ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 9; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; FETUS; GENE EXPRESSION; GLOMERULUS; HEART TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TISSUE; LIVER TISSUE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSEUDOTYPING; SPLEEN TISSUE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

EID: 85015657923     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.14     Document Type: Article

References (33)

1. 1 Schedl, A, Renal abnormalities and their developmental origin. Nat Rev Genet 8 (2007), 791–802.
2. 2 Song, R, Yosypiv, IV, Genetics of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol 26 (2011), 353–364.
3. 3 Ahrabi, AK, Jouret, F, Marbaix, E, Delporte, C, Horie, S, Mulroy, S, et al. Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrol Dial Transplant 25 (2010), 1067–1078.
4. 4 Martinovic-Bouriel, J, Benachi, A, Bonnière, M, Brahimi, N, Esculpavit, C, Morichon, N, et al. PAX2 mutations in fetal renal hypodysplasia. Am J Med Genet A 152A (2010), 830–835.
5. 5 Nakai, H, Asanuma, H, Shishido, S, Kitahara, S, Yasuda, K, Changing concepts in urological management of the congenital anomalies of kidney and urinary tract, CAKUT. Pediatr Int 45 (2003), 634–641.
6. 6 Kuwayama, F, Miyazaki, Y, Ichikawa, I, Embryogenesis of the congenital anomalies of the kidney and the urinary tract. Nephrol Dial Transplant 17:suppl. 9 (2002), 45–47.
7. 7 Schachtner, S, Buck, C, Bergelson, J, Baldwin, H, Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Ther 6 (1999), 1249–1257.
8. 8 Bilbao, R, Reay, DP, Li, J, Xiao, X, Clemens, PR, Patterns of gene expression from in utero delivery of adenoviral-associated vector serotype 1. Hum Gene Ther 16 (2005), 678–684.
9. 9 Mitchell, M, Jerebtsova, M, Batshaw, ML, Newman, K, Ye, X, Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Ther 7 (2000), 1986–1992.
10. 10 Koppanati, BM, Li, J, Xiao, X, Clemens, PR, Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders. Gene Ther 16 (2009), 1130–1137.
11. 11 Bouchard, S, MacKenzie, TC, Radu, AP, Hayashi, S, Peranteau, WH, Chirmule, N, et al. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice. J Gene Med 5 (2003), 941–950.
12. 12 Lipshutz, GS, Titre, D, Brindle, M, Bisconte, AR, Contag, CH, Gaensler, KM, Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol Ther 8 (2003), 90–98.
13. 13 Lipshutz, GS, Gruber, CA, Cao, Y, Hardy, J, Contag, CH, Gaensler, KM, In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 3 (2001), 284–292.
14. 14 David, AL, McIntosh, J, Peebles, DM, Cook, T, Waddington, S, Weisz, B, et al. Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep. Hum Gene Ther 22 (2011), 419–426.
15. 15 Binny, C, McIntosh, J, Della Peruta, M, Kymalainen, H, Tuddenham, EG, Buckley, SM, et al. AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage. Blood 119 (2012), 957–966.
16. 16 Sabatino, DE, Mackenzie, TC, Peranteau, W, Edmonson, S, Campagnoli, C, Liu, YL, et al. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol Ther 15 (2007), 1677–1685.
17. 17 Lipshutz, GS, Flebbe-Rehwaldt, L, Gaensler, KM, Adenovirus-mediated gene transfer in the midgestation fetal mouse. J Surg Res 84 (1999), 150–156.
18. 18 Boyle, MP, Enke, RA, Adams, RJ, Guggino, WB, Zeitlin, PL, In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol Ther 4 (2001), 115–121.
19. 19 Ochiya, T, Takahama, Y, Baba-Toriyama, H, Tsukamoto, M, Yasuda, Y, Kikuchi, H, et al. Evaluation of cationic liposome suitable for gene transfer into pregnant animals. Biochem Biophys Res Commun 258 (1999), 358–365.
20. 20 Tsukamoto, M, Ochiya, T, Yoshida, S, Sugimura, T, Terada, M, Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice. Nat Genet 9 (1995), 243–248.
21. 21 Kikuchi, N, Nakamura, S, Ohtsuka, M, Kimura, M, Sato, M, Possible mechanism of gene transfer into early to mid-gestational mouse fetuses by tail vein injection. Gene Ther 9 (2002), 1529–1541.
22. 22 Srivastava, AS, Chauhan, DP, Carrier, E, In utero detection of T7 phage after systemic administration to pregnant mice. Biotechniques 37 (2004), 81–83.
23. 23 Schievenbusch, S, Strack, I, Scheffler, M, Nischt, R, Coutelle, O, Hösel, M, et al. Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. Mol Ther 18 (2010), 1302–1309.
24. 24 Wu, Z, Asokan, A, Samulski, RJ, Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 14 (2006), 316–327.
25. 25 Lipps, BV, Mayor, HD, Transplacental infection with adeno-associated virus type 1 in mice. Intervirology 14 (1980), 118–123.
26. 26 Isaka, Y, Gene therapy targeting kidney diseases: routes and vehicles. Clin Exp Nephrol 10 (2006), 229–235.
27. 27 Luo, X, Hall, G, Li, S, Bird, A, Lavin, PJ, Winn, MP, et al. Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector. Mol Ther 19 (2011), 1961–1970.
28. 28 Sénac, JS, Chandler, RJ, Sysol, JR, Li, L, Venditti, CP, Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene delivery. Gene Ther 19 (2012), 385–391.
29. 29 Zincarelli, C, Soltys, S, Rengo, G, Rabinowitz, JE, Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 16 (2008), 1073–1080.
30. 30 Moeller, MJ, Sanden, SK, Soofi, A, Wiggins, RC, Holzman, LB, Two gene fragments that direct podocyte-specific expression in transgenic mice. J Am Soc Nephrol 13 (2002), 1561–1567.
31. 31 Dressler, GR, Advances in early kidney specification, development and patterning. Development 136 (2009), 3863–3874.
32. 32 Burguete, T, Rabreau, M, Fontanges-Darriet, M, Roset, E, Hager, HD, Köppel, A, et al. Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum Reprod 14 (1999), 2396–2401.
33. 33 Urabe, M, Ding, C, Kotin, RM, Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13 (2002), 1935–1943.